CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis.

Saved in:
Bibliographic Details
Title: CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis.
Authors: Dennys CN; Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Roussel F; Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Rodrigo R; Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Zhang X; Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Sierra Delgado A; Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Hartlaub A; Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Saelim-Ector A; Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Ray W; Mathematics Department, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA., Heintzman S; Department of Neurology, The Ohio State University Medical Center, Columbus, Ohio, USA., Fox A; Department of Neurology, The Ohio State University Medical Center, Columbus, Ohio, USA., Kolb SJ; Department of Neurology, The Ohio State University Medical Center, Columbus, Ohio, USA.; Department of Biological Chemistry & Pharmacology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.; Molecular, Cellular & Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio, USA.; Department of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Beckman J; Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA., Franco MC; Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon, USA., Meyer K; Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.; Molecular, Cellular & Developmental Biology Graduate Program, The Ohio State University, Columbus, Ohio, USA.; Department of Pediatrics, The Ohio State University Medical Center, Columbus, Ohio, USA.
Source: Glia [Glia] 2023 Feb; Vol. 71 (2), pp. 350-365. Date of Electronic Publication: 2022 Oct 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8806785 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1136 (Electronic) Linking ISSN: 08941491 NLM ISO Abbreviation: Glia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1098-1136
DOI:10.1002/glia.24278